Targeting B-cell lymphoma 6 (BCL6) for the treatment of diffuse large B-cell lymphomas (DLBCLs)

被引：0
|
作者：
Cardenas, Mariano [2 ]
Yu, Wenbo [1 ]
Zhu, Shilei [1 ]
Cerchietti, Leandro C. [2 ]
Melnick, Ari [2 ]
MacKerell, Alexander D., Jr. [1 ]
Xue, Fengtian [1 ]
机构：
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA
[2] Cornell Univ, Dept Pharmacol, New York, NY 10065 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 246卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
318-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [31] What does MYC, BCL2, and BCL6 genes 'rearranged' mean in large cell/diffuse B-cell lymphomas?
    Trombetta, Domenico
    Zanelli, Magda
    Garuti, Anna
    Carosi, Illuminato
    Mastracci, Luca
    Ascani, Stefano
    Graziano, Paolo
    Parente, Paola
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 240
  • [32] Combinatorial Targeting of BCL6 and Anti-Apoptotic Proteins in Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
    Dupont, Thibault
    Dong, Zhenghong
    Yang, ShaoNing
    Melnick, Ari
    Cerchietti, Leandro
    BLOOD, 2012, 120 (21)
  • [33] Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis
    Mozos, Ana
    Ye, Hongtao
    Chuang, Wen-Yu
    Chu, Jan-Show
    Huang, Wan-Ting
    Chen, Han-Ku
    Hsu, Yung-Hsiang
    Bacon, Chris M.
    Du, Ming-Qing
    Campo, Elias
    Chuang, Shih-Sung
    MODERN PATHOLOGY, 2009, 22 (09) : 1210 - 1217
  • [34] Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma
    Dunleavy, Kieron
    Erdmann, Tabea
    Lenz, Georg
    CANCER TREATMENT REVIEWS, 2018, 65 : 41 - 46
  • [35] Extra copies of MYC, BCL2, and BCL6 and outcome in patients with diffuse large B-cell lymphoma
    Sermer, David
    Bobillo, Sabela
    Dogan, Ahmet
    Zhang, Yanming
    Seshan, Venkatraman
    Lavery, Jessica A.
    Batlevi, Connie
    Caron, Philip
    Hamilton, Audrey
    Hamlin, Paul
    Horwitz, Steven
    Joffe, Erel
    Kumar, Anita
    Matasar, Matthew
    Noy, Ariela
    Owens, Colette
    Moskowitz, Alison
    Palomba, M. Lia
    Straus, David
    von Keudell, Gottfried
    Rodriguez-Rivera, Ildefonso
    Falchi, Lorenzo
    Zelenetz, Andrew
    Yahalom, Joachim
    Younes, Anas
    BLOOD ADVANCES, 2020, 4 (14) : 3382 - 3390
  • [36] ARSENIC TRIOXIDE TARGETS BCL6 FOR DEGRADATION AND INHIBITS THE PROLIFERATION OF BCL6-DEPENDENT DIFFUSE LARGE B-CELL LYMPHOMA
    Tse, E.
    Yue, K.
    Chau, D.
    Kwong, Y. -L.
    HAEMATOLOGICA, 2017, 102 : 571 - 571
  • [37] Treatment of diffuse large B-cell lymphomas
    C. Zwick
    N. Murawski
    Michael Pfreundschuh
    memo - Magazine of European Medical Oncology, 2009, 2 (3) : 150 - 153
  • [38] Treatment of Diffuse Large B-Cell Lymphomas
    Magomedova, Aminat U.
    Kravchenko, Sergey K.
    Kremenetskaya, Alexandra
    Zvonkov, Evgenyi
    Baryakh, Elena
    Mangasarova, Yana
    Kaplanskaya, Irina
    Samojlova, Rima
    Vorobjev, Ivan A.
    Obuchova, Tatjana
    Karagjuljan, Suren
    Klyasova, Galina
    Shulutko, Elena
    Galstyan, Gennadii
    Marjin, Dmitrii
    Gabeeva, Nelya
    Vorobjev, Andrey
    BLOOD, 2011, 118 (21) : 1153 - 1154
  • [39] Treatment of diffuse large B-cell lymphomas
    Zwick, C.
    Murawski, N.
    Pfreundschuh, M.
    MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2009, 2 (03) : 150 - 153
  • [40] Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement
    Carreras, Joaquim
    Ikoma, Haruka
    Kikuti, Yara Yukie
    Miyaoka, Masashi
    Hiraiwa, Shinichiro
    Tomita, Sakura
    Kondo, Yusuke
    Ito, Atsushi
    Nagase, Shunsuke
    Miura, Hisanobu
    Kawada, Hiroshi
    Roncador, Giovanna
    Campo, Elias
    Hamoudi, Rifat
    Nakamura, Naoya
    VIRCHOWS ARCHIV, 2024, 484 (04) : 657 - 676
12345